Introduction
An emerging clinical role for community pharmacists is to become actively involved in the follow-up care of patients who are discharged back into the community (transfer of care services) by promoting better medication adherence and by contributing to the safe, effective, and efficient use of medication. 1 Recent research highlights how this extended role of community pharmacists could help to reduce drug-related adverse events, unnecessary health provider visits, hospitalizations, and readmissions while strengthening integrated primary care delivery across the healthcare system.
1,2
Risk prediction models have been developed to effectively target the offering of postdischarge interventions to reduce patient hospital readmission. These tools aim to standardize the offer and provision of services that could otherwise be dependent upon professional and clinical expertise, knowledge and bias. Despite over 30 years of work to develop and optimize a risk prediction tool, there is limited consensus on the fundamental patient parameters that are most useful to target delivery of readmission-reducing interventions. [3] [4] [5] A consensus methodological approach was adopted in this study to address a gap in the literature by identifying appropriate referral criteria of hospital inpatients for follow-up care in the primary care setting.
Methods

Phase 1
Semistructured interviews were conducted in February 2018 with a small number (n=4) of experts purposively sampled due to their involvement in delivering, designing or managing transfer of care services between hospital and community pharmacy. The interviewer probed about potential referral criteria for patients to be offered postdischarge care. Transcribed interview data were analyzed using inductive thematic analysis to generate category systems and repeated themes. 
Phase 2
The stakeholder interviews informed the design of a survey tool to be employed in an adapted two-round Delphi consensus activity. 7 The survey was reviewed and piloted by two clinical pharmacists for clarity of language and face validity. The Delphi panel members included senior pharmacists, pharmacy directors and managers across the primary and secondary care sectors nationwide whom were known to the study team members and who are involved in the design, delivery and management of transfer of care services. These individuals were recruited through a combination of convenience and snowball sampling.
Participants were asked to indicate which patient characteristics were important to consider when deciding whether to offer postdischarge care, and then asked to rank these identified characteristics by level of importance (1=not important, 10=very important). Based on the first round of responses, a refined survey was sent out again to the same stakeholders to validate the patient referral criteria.
Favourable ethical approval was granted by the Faculty of Medical Sciences, Newcastle University.
Results
The early interviews offered a range of factors to be considered when determining whether an inpatient should be referred to their community pharmacist upon discharge for follow-up care.
Of 29 invited panellists, 10 consented to take part. The participants represented primary (n=2) and secondary care settings (n=7), and represented the North East (n=2), the South (n=4), the North West (n=2), and the South East (n=2) regions of England. All 10 participants completed all questions giving a response rate at round 1 of 34%. These 10 participants also completed round 2 of the Delphi. Table 1 shows whether the participants thought the patient characteristics were important or not and their relative ranking of importance. Round 2 results are also displayed where 3 out of 5 factors achieved a high level of consensus (≥90%).
Discussion
This study presents that consensus was achieved across three inpatient referral criteria:
1. Changed medication as inpatient 2. New medication on discharge 3. High-risk drugs This work offers service designers, providers and managers some guidance on inpatients who may be appropriate to refer through transfer of care, or postdischarge services. This study is based on expert opinion of a small number of panellists self-selecting from practice who have a keen interest in transfer of care services. These factors limit the findings as a larger sample size from a wider population would improve overall reliability.
Further research is also required to explore the feasibility of adopting this referral criteria and empirically assessing if patients fitting this criteria benefit most from postdischarge care from community pharmacists.
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